Nasal Drug Delivery Technology Market by Dosage Form (Nasal Drops, Sprays, Powder, Gel), System (Multidose, Unit Dose, BI-Dose), Therapeutic Applications (Rhinitis, Congestion, Vaccinations), End User (Hospitals, Homecare) - Global Forecast to 2021
The global nasal drug delivery technology market is projected to reach USD 64.20 billion by 2021 from USD 44.00 billion in 2016, at a CAGR of 6.5% during the forecast period.
Increasing patient preference for nasal drug delivery as a result of easy administration & better efficacy and growing self-administration practices among the patients are the factors driving the growth of this market. Whereas, growth among over-the-counter nasal drugs and increasing focus on alternative routes of drug delivery such as nasal drug delivery offer significant growth opportunities for players operating in this market. On the other hand, complications associated with the overuse of nasal sprays may restraint the growth of the market.
The nasal drug delivery technology market is segmented based on dosage form, therapeutic application, end user, system, container, and region. On the basis of container, the market is segmented into pressurized and non-pressurized containers. In 2016, the non-pressurized containers segment is expected to account for the largest share of the market. The large share of this segment can primarily be attributed to advantages such as better versatility and reliability, instant availability, self-containment, better portability, and low-cost medical aerosol delivery. In addition, the increasing usage of these devices for the treatment of asthma and chronic obstructive pulmonary disease (COPD) is expected to further drive the growth of this market in the coming years.
On the basis of end user, the market is segmented into hospitals and home care settings. In 2016, the home care settings segment is expected to account for the largest share of the market, primarily due to the increasing preference for self-administration among patients.
Asia is expected to be fastest-growing region in the nasal drug delivery technology market from 2016 to 2021. Opportunities in the Asian market have attracted huge investments by major companies in the area of R&D activities. In addition, the region has low costs of labor and clinical trials, which has further served to draw market players to Asia.
Prominent players in the nasal drug delivery technology market include Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Pfizer, Inc. (U.S.), AstraZeneca plc. (U.S.), AptarGroup (U.S.), and GlaxoSmithKline plc (U.K.).
Research Coverage:
The report defines, describes, and forecast the nasal drug delivery technology market on the basis of dosage form, therapeutic application, end user, system, container, and region. It provides detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, challenges). The study tracks and analyzes competitive developments such as joint ventures, mergers and acquisitions, new product developments, and expansions in the nasal drug delivery technology market across to four main regions, namely, North America, Asia, Europe, and the Rest of the World (RoW).
Reasons to buy the report:
The report on the nasal drug delivery technology market provides quantitative information for clients seeking market size information on various segments of this market. This report also provides access to the quantitative data on the nasal drug delivery technology market. This report covers –
Increasing patient preference for nasal drug delivery as a result of easy administration & better efficacy and growing self-administration practices among the patients are the factors driving the growth of this market. Whereas, growth among over-the-counter nasal drugs and increasing focus on alternative routes of drug delivery such as nasal drug delivery offer significant growth opportunities for players operating in this market. On the other hand, complications associated with the overuse of nasal sprays may restraint the growth of the market.
The nasal drug delivery technology market is segmented based on dosage form, therapeutic application, end user, system, container, and region. On the basis of container, the market is segmented into pressurized and non-pressurized containers. In 2016, the non-pressurized containers segment is expected to account for the largest share of the market. The large share of this segment can primarily be attributed to advantages such as better versatility and reliability, instant availability, self-containment, better portability, and low-cost medical aerosol delivery. In addition, the increasing usage of these devices for the treatment of asthma and chronic obstructive pulmonary disease (COPD) is expected to further drive the growth of this market in the coming years.
On the basis of end user, the market is segmented into hospitals and home care settings. In 2016, the home care settings segment is expected to account for the largest share of the market, primarily due to the increasing preference for self-administration among patients.
Asia is expected to be fastest-growing region in the nasal drug delivery technology market from 2016 to 2021. Opportunities in the Asian market have attracted huge investments by major companies in the area of R&D activities. In addition, the region has low costs of labor and clinical trials, which has further served to draw market players to Asia.
Prominent players in the nasal drug delivery technology market include Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Pfizer, Inc. (U.S.), AstraZeneca plc. (U.S.), AptarGroup (U.S.), and GlaxoSmithKline plc (U.K.).
Research Coverage:
The report defines, describes, and forecast the nasal drug delivery technology market on the basis of dosage form, therapeutic application, end user, system, container, and region. It provides detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, challenges). The study tracks and analyzes competitive developments such as joint ventures, mergers and acquisitions, new product developments, and expansions in the nasal drug delivery technology market across to four main regions, namely, North America, Asia, Europe, and the Rest of the World (RoW).
Reasons to buy the report:
The report on the nasal drug delivery technology market provides quantitative information for clients seeking market size information on various segments of this market. This report also provides access to the quantitative data on the nasal drug delivery technology market. This report covers –
- Current and forecast assessment of the nasal drug delivery technology market.
- Country-wise assessment of each of the segments
- Global market share analysis for major segments of the nasal drug delivery technology market
- Adoption trends of various nasal drug delivery technologies for major geographic markets
- Five-year coverage of strategic developments of top players in the nasal drug delivery technology market
- Product Portfolio mapping of leading players in the nasal drug delivery technology market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.4 LIMITATIONS
1.5 MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 MARKET SIZE ESTIMATION
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.3 KEY DATA POINT FROM SECONDARY SOURCES
2.4 KEY DATA POINT FROM PRIMARY SOURCES
2.5 KEY INDUSTRY INSIGHTS
2.6 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
5.3 MARKET DYNAMICS
5.3.1 MARKET DRIVERS
5.3.1.1 Increasing patient preference for nasal drug delivery as a result of easy administration and better efficacy
5.3.1.2 Growing adoption of self-administration practices
5.3.2 MARKET RESTRAINTS
5.3.2.1 Complications associated with the overuse of nasal sprays
5.3.3 MARKET OPPORTUNITIES
5.3.3.1 Over-the-counter nasal drugs
5.3.3.2 Increasing focus on alternative routes such as nasal drug delivery
5.3.4 MARKET CHALLENGES
5.3.4.1 Regulatory hurdles
6 REGULATORY SCENARIO
7 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY DOSAGE FORM
7.1 INTRODUCTION
7.2 NASAL SPRAY
7.3 NASAL DROPS AND LIQUIDS
7.4 NASAL GELS
7.5 NASAL POWDERS
7.6 OTHERS
8 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY CONTAINERS
8.1 INTRODUCTION
8.2 NON-PRESSURIZED CONTAINERS
8.4 PRESSURIZED CONTAINERS
9 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY SYSTEMS
9.1 INTRODUCTION
9.2 MULTI DOSE
9.3 BI-DOSE
9.4 UNIT DOSE
10 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY THERAPEUTIC APPLICATION
10.1 ALLERGIC AND NON-ALLERGIC RHINITIS
10.2 NASAL CONGESTION
10.3 VACCINATIONS
10.5 OTHER APPLICATIONS
11 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY END USER
11.1 INTRODUCTION
11.2 HOSPITALS
11.3 HOME HEALTH CARE
12 GEOGRAPHIC ANALYSIS
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 U.S.
12.2.2 CANADA
12.3 EUROPE
12.3.1 GERMANY
12.3.2 FRANCE
12.3.3 U.K.
12.3.4 REST OF THE EUROPE (ROE)
12.4 ASIA
12.4.1 JAPAN
12.4.2 INDIA
12.4.3 CHINA
12.4.4 ROA
12.5 REST OF THE WORLD (ROW)
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 MARKET SHARE ANALYSIS
13.3 COMPETITIVE SITUATIONS & TRENDS
14 COMPANY PROFILES
14.1 INTRODUCTION
14.2 MERCK & CO., INC.
14.3 NOVARTIS AG
14.4 GLAXOSMITHKLINE PLC
14.5 JOHNSON & JOHNSON SERVICES, INC.
14.6 PFIZER INC.
14.7 ASTRAZENECA PLC
14.8 APTARGROUP, INC.
14.9 AEGIS THERAPEUTICS LLC
14.10 3M
14.10.4 MNM VIEW
14.11 BECTON, DICKINSON AND COMPANY
*The segment/chapters will be added according to the availability of the information
**Tentative list of companies added, This is subjected to the addition and deletion of companies
15 APPENDIX
15.1 INSIGHTS FROM INDUSTRY EXPERTS
15.2 DISCUSSION GUIDE
15.3 KNOWLEDGE STORE
15.4 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
15.5 RELATED REPORTS
15.6 AUTHORS DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.4 LIMITATIONS
1.5 MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 MARKET SIZE ESTIMATION
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.3 KEY DATA POINT FROM SECONDARY SOURCES
2.4 KEY DATA POINT FROM PRIMARY SOURCES
2.5 KEY INDUSTRY INSIGHTS
2.6 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
5.3 MARKET DYNAMICS
5.3.1 MARKET DRIVERS
5.3.1.1 Increasing patient preference for nasal drug delivery as a result of easy administration and better efficacy
5.3.1.2 Growing adoption of self-administration practices
5.3.2 MARKET RESTRAINTS
5.3.2.1 Complications associated with the overuse of nasal sprays
5.3.3 MARKET OPPORTUNITIES
5.3.3.1 Over-the-counter nasal drugs
5.3.3.2 Increasing focus on alternative routes such as nasal drug delivery
5.3.4 MARKET CHALLENGES
5.3.4.1 Regulatory hurdles
6 REGULATORY SCENARIO
7 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY DOSAGE FORM
7.1 INTRODUCTION
7.2 NASAL SPRAY
7.3 NASAL DROPS AND LIQUIDS
7.4 NASAL GELS
7.5 NASAL POWDERS
7.6 OTHERS
8 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY CONTAINERS
8.1 INTRODUCTION
8.2 NON-PRESSURIZED CONTAINERS
8.4 PRESSURIZED CONTAINERS
9 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY SYSTEMS
9.1 INTRODUCTION
9.2 MULTI DOSE
9.3 BI-DOSE
9.4 UNIT DOSE
10 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY THERAPEUTIC APPLICATION
10.1 ALLERGIC AND NON-ALLERGIC RHINITIS
10.2 NASAL CONGESTION
10.3 VACCINATIONS
10.5 OTHER APPLICATIONS
11 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY END USER
11.1 INTRODUCTION
11.2 HOSPITALS
11.3 HOME HEALTH CARE
12 GEOGRAPHIC ANALYSIS
12.1 INTRODUCTION
12.2 NORTH AMERICA
12.2.1 U.S.
12.2.2 CANADA
12.3 EUROPE
12.3.1 GERMANY
12.3.2 FRANCE
12.3.3 U.K.
12.3.4 REST OF THE EUROPE (ROE)
12.4 ASIA
12.4.1 JAPAN
12.4.2 INDIA
12.4.3 CHINA
12.4.4 ROA
12.5 REST OF THE WORLD (ROW)
13 COMPETITIVE LANDSCAPE
13.1 OVERVIEW
13.2 MARKET SHARE ANALYSIS
13.3 COMPETITIVE SITUATIONS & TRENDS
14 COMPANY PROFILES
14.1 INTRODUCTION
14.2 MERCK & CO., INC.
14.3 NOVARTIS AG
14.4 GLAXOSMITHKLINE PLC
14.5 JOHNSON & JOHNSON SERVICES, INC.
14.6 PFIZER INC.
14.7 ASTRAZENECA PLC
14.8 APTARGROUP, INC.
14.9 AEGIS THERAPEUTICS LLC
14.10 3M
14.10.4 MNM VIEW
14.11 BECTON, DICKINSON AND COMPANY
*The segment/chapters will be added according to the availability of the information
**Tentative list of companies added, This is subjected to the addition and deletion of companies
15 APPENDIX
15.1 INSIGHTS FROM INDUSTRY EXPERTS
15.2 DISCUSSION GUIDE
15.3 KNOWLEDGE STORE
15.4 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
15.5 RELATED REPORTS
15.6 AUTHORS DETAILS
LIST OF TABLES
Table 1 NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 2 NASAL SPRAYS DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 3 NASAL DROPS & LIQUIDS DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 4 NASAL DROPS & LIQUIDS DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 5 NASAL DRUG DELIVERY MARKET SIZE, BY CONTAINER TYPE, 2014-2021 (USD MILLION)
Table 6 NASAL DRUG DELIVERY MARKET SIZE FOR NON-PRESSURIZED CONTAINERS, BY REGION, 2014-2021 (USD MILLION)
Table 7 NASAL DRUG DELIVERY MARKET SIZE FOR PRESSURIZED CONTAINERS, BY REGION, 2014-2021 (USD MILLION)
Table 8 NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 9 NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR MULTI-DOSE SYSTEMS, BY REGION, 2014–2021 (USD MILLION)
Table 10 NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR BI-DOSE SYSTEMS, BY REGION, 2014–2021 (USD MILLION)
Table 11 NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR UNIT-DOSE SYSTEMS, BY REGION, 2014–2021 (USD MILLION)
Table 12 NASAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
Table 13 NASAL DRUG DELIVERY MARKET SIZE FOR ALLERGIC AND NON-ALLERGIC RHINITIS, BY REGION, 2014–2021 (USD MILLION)
Table 14 NASAL DRUG DELIVERY MARKET SIZE FOR NASAL CONGESTION, BY REGION, 2014-2021 (USD MILLION)
Table 15 NASAL DRUG DELIVERY MARKET SIZE FOR VACCINATION, BY REGION, 2014-2021 (USD MILLION)
Table 16 NASAL DRUG DELIVERY MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
Table 17 NASAL DRUG DELIVERY MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
Table 18 NASAL DRUG DELIVERY MARKET SIZE FOR HOMECARE SETTINGS, BY REGION, 2014–2021 (USD MILLION)
Table 19 NASAL DRUG DELIVERY MARKET SIZE FOR HOSPITALS, BY REGION, 2014–2021 (USD MILLION)
Table 20 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 21 NORTH AMERICA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 22 NORTH AMERICA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 23 NORTH AMERICA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 24 NORTH AMERICA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 25 NORTH AMERICA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 26 NORTH AMERICA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 27 U.S.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 28 U.S.: NASAL DRUG DELIVERY MARKET, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 29 U.S.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 30 U.S.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 31 U.S.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 32 CANADA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION
Table 33 CANADA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 34 CANADA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 35 CANADA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 36 CANADA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 37 EUROPE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 38 EUROPE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 39 EUROPE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 40 EUROPE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 41 EUROPE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 42 GERMANY: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 43 GERMANY: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 44 GERMANY: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 45 GERMANY: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 46 GERMANY: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 47 U.K.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 48 U.K.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 49 U.K.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 50 U.K.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 51 U.K.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 52 FRANCE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 53 FRANCE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 54 FRANCE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 55 FRANCE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 56 FRANCE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 57 ROE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 58 ROE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 59 ROE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 60 ROE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 61 ROE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 62 ASIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 63 ASIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 64 ASIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 65 ASIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 66 ASIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 67 JAPAN: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 68 JAPAN: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 69 JAPAN: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 70 JAPAN: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 71 JAPAN: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 72 CHINA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 73 CHINA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 74 CHINA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 75 CHINA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 76 CHINA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 77 INDIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, SYSTEM, 2014–2021 (USD MILLION)
Table 78 INDIA: NASAL DRUG DELIVERY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 79 INDIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 80 INDIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 81 INDIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 82 ROA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 83 ROA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 84 ROA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 85 ROA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION
Table 86 ROA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 87 ROW: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 88 ROW: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 89 ROW: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 90 ROW: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 91 ROW: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 92 PRODUCT LAUNCHES AND APPROVALS, 2014–2016
Table 93 COLLABORATIONS, 2014–2016
Table 94 EXPANSIONS, 2014–2016
Table 95 MARKET RANKING FOR THE KEY PLAYERS IN 2016
Table 1 NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 2 NASAL SPRAYS DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 3 NASAL DROPS & LIQUIDS DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 4 NASAL DROPS & LIQUIDS DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 5 NASAL DRUG DELIVERY MARKET SIZE, BY CONTAINER TYPE, 2014-2021 (USD MILLION)
Table 6 NASAL DRUG DELIVERY MARKET SIZE FOR NON-PRESSURIZED CONTAINERS, BY REGION, 2014-2021 (USD MILLION)
Table 7 NASAL DRUG DELIVERY MARKET SIZE FOR PRESSURIZED CONTAINERS, BY REGION, 2014-2021 (USD MILLION)
Table 8 NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 9 NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR MULTI-DOSE SYSTEMS, BY REGION, 2014–2021 (USD MILLION)
Table 10 NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR BI-DOSE SYSTEMS, BY REGION, 2014–2021 (USD MILLION)
Table 11 NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE FOR UNIT-DOSE SYSTEMS, BY REGION, 2014–2021 (USD MILLION)
Table 12 NASAL DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
Table 13 NASAL DRUG DELIVERY MARKET SIZE FOR ALLERGIC AND NON-ALLERGIC RHINITIS, BY REGION, 2014–2021 (USD MILLION)
Table 14 NASAL DRUG DELIVERY MARKET SIZE FOR NASAL CONGESTION, BY REGION, 2014-2021 (USD MILLION)
Table 15 NASAL DRUG DELIVERY MARKET SIZE FOR VACCINATION, BY REGION, 2014-2021 (USD MILLION)
Table 16 NASAL DRUG DELIVERY MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
Table 17 NASAL DRUG DELIVERY MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
Table 18 NASAL DRUG DELIVERY MARKET SIZE FOR HOMECARE SETTINGS, BY REGION, 2014–2021 (USD MILLION)
Table 19 NASAL DRUG DELIVERY MARKET SIZE FOR HOSPITALS, BY REGION, 2014–2021 (USD MILLION)
Table 20 GLOBAL NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 21 NORTH AMERICA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
Table 22 NORTH AMERICA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 23 NORTH AMERICA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 24 NORTH AMERICA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 25 NORTH AMERICA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 26 NORTH AMERICA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 27 U.S.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 28 U.S.: NASAL DRUG DELIVERY MARKET, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 29 U.S.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 30 U.S.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 31 U.S.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 32 CANADA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION
Table 33 CANADA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 34 CANADA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 35 CANADA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 36 CANADA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 37 EUROPE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 38 EUROPE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 39 EUROPE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 40 EUROPE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 41 EUROPE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 42 GERMANY: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 43 GERMANY: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 44 GERMANY: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 45 GERMANY: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 46 GERMANY: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 47 U.K.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 48 U.K.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 49 U.K.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 50 U.K.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 51 U.K.: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 52 FRANCE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 53 FRANCE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 54 FRANCE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 55 FRANCE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 56 FRANCE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 57 ROE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 58 ROE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 59 ROE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 60 ROE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 61 ROE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 62 ASIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 63 ASIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 64 ASIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 65 ASIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 66 ASIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 67 JAPAN: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 68 JAPAN: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 69 JAPAN: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 70 JAPAN: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 71 JAPAN: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 72 CHINA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 73 CHINA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 74 CHINA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 75 CHINA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 76 CHINA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 77 INDIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, SYSTEM, 2014–2021 (USD MILLION)
Table 78 INDIA: NASAL DRUG DELIVERY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 79 INDIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 80 INDIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 81 INDIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 82 ROA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 83 ROA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 84 ROA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 85 ROA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION
Table 86 ROA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 87 ROW: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY SYSTEM, 2014–2021 (USD MILLION)
Table 88 ROW: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY DOSAGE FORM, 2014–2021 (USD MILLION)
Table 89 ROW: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
Table 90 ROW: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY CONTAINER, 2014–2021 (USD MILLION)
Table 91 ROW: NASAL DRUG DELIVERY TECHNOLOGY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD MILLION)
Table 92 PRODUCT LAUNCHES AND APPROVALS, 2014–2016
Table 93 COLLABORATIONS, 2014–2016
Table 94 EXPANSIONS, 2014–2016
Table 95 MARKET RANKING FOR THE KEY PLAYERS IN 2016
LIST OF FIGURES
Figure 1 SEGMENTATION & COVERAGE
Figure 2 RESEARCH DESIGN
Figure 3 NASAL DRUG DELIVERY MARKET: TOP DOWN APPROACH
Figure 4 NASAL DRUG DELIVERY MARKET: BOTTOM UP APPROACH
Figure 5 DATA TRIANGULATION METHODOLOGY
Figure 6 ASSUMPTIONS FOR THE STUDY
Figure 7 NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY DOSAGE FORM, 2016 VS. 2021
Figure 8 NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY SYSTEMS, 2016 VS. 2021
Figure 9 NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY END USER, 2016 VS. 2021
Figure 10 NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY THERAPEUTIC APPLICATION, 2016 VS. 2021
Figure 11 NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY CONTAINER, 2016 VS. 2021
Figure 12 NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY REGION, 2016-2021
Figure 13 NASAL DRUG DELIVERY TECHNOLOGY MARKET TO SHOWCASE LUCRATIVE GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD
Figure 14 HOME CARE SETTINGS SEGMENT IS EXPECTED TO GROW AT A HIGHEST CAGR, BY END USER, (2016-2021)
Figure 15 MULTI-DOSE SYSTEMS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET, BY SYSTEM, IN 2016
Figure 16 ALLERIC AND NON-ALLERGIC RHINITIS TO DOMINATE THE MARKET, BY THERAPEUTIC APPLICATION, IN 2016
Figure 17 NASAL DRUG DELIVERY TECHNOLOGY MARKET IN JAPAN TO REGISTER THE HIGHEST CAGR (2016–2021)
Figure 18 NASAL DRUG DELIVERY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
Figure 19 NORTH AMERICA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SNAPSHOT
Figure 20 EUROPE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SNAPSHOT
Figure 21 ASIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SNAPSHOT
Figure 22 KEY PLAYERS ADOPTED ORGANIC AND INORGANIC GROWTH STRATEGIES BETWEEN 2014 AND 2016
Figure 23 MARKET EVOLUTION FRAMEWORK
Figure 24 BATTLE FOR MARKET SHARE: PRODUCT LAUNCHES AND APPROVALS—KEY STRATEGIES ADOPTED BY MARKET PLAYERS
Figure 25 GEOGRAPHIC REVENUE MIX OF TOP FIVE MARKET PLAYERS (2015)
Figure 26 MERCK & CO., INC.: COMPANY SNAPSHOT (2015)
Figure 27 NOVARTIS AG: COMPANY SNAPSHOT (2015)
Figure 28 GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT (2015)
Figure 29 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2015)
Figure 30 PFIZER, INC: COMPANY SNAPSHOT (2015)
Figure 31 ASTRAZENECA PLC: COMPANY SNAPSHOT (2015)
Figure 32 APTARGROUP, INC.: COMPANY SNAPSHOT (2015)
Figure 33 AEGIS THERAPEUTICS, LLC: COMPANY SNAPSHOT (2015)
Figure 34 3M: COMPANY SNAPSHOT (2015)
Figure 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2015)
Figure 36 INSIGHTS FROM INDUSTRY EXPERTS
Figure 1 SEGMENTATION & COVERAGE
Figure 2 RESEARCH DESIGN
Figure 3 NASAL DRUG DELIVERY MARKET: TOP DOWN APPROACH
Figure 4 NASAL DRUG DELIVERY MARKET: BOTTOM UP APPROACH
Figure 5 DATA TRIANGULATION METHODOLOGY
Figure 6 ASSUMPTIONS FOR THE STUDY
Figure 7 NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY DOSAGE FORM, 2016 VS. 2021
Figure 8 NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY SYSTEMS, 2016 VS. 2021
Figure 9 NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY END USER, 2016 VS. 2021
Figure 10 NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY THERAPEUTIC APPLICATION, 2016 VS. 2021
Figure 11 NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY CONTAINER, 2016 VS. 2021
Figure 12 NASAL DRUG DELIVERY TECHNOLOGY MARKET, BY REGION, 2016-2021
Figure 13 NASAL DRUG DELIVERY TECHNOLOGY MARKET TO SHOWCASE LUCRATIVE GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD
Figure 14 HOME CARE SETTINGS SEGMENT IS EXPECTED TO GROW AT A HIGHEST CAGR, BY END USER, (2016-2021)
Figure 15 MULTI-DOSE SYSTEMS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET, BY SYSTEM, IN 2016
Figure 16 ALLERIC AND NON-ALLERGIC RHINITIS TO DOMINATE THE MARKET, BY THERAPEUTIC APPLICATION, IN 2016
Figure 17 NASAL DRUG DELIVERY TECHNOLOGY MARKET IN JAPAN TO REGISTER THE HIGHEST CAGR (2016–2021)
Figure 18 NASAL DRUG DELIVERY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
Figure 19 NORTH AMERICA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SNAPSHOT
Figure 20 EUROPE: NASAL DRUG DELIVERY TECHNOLOGY MARKET SNAPSHOT
Figure 21 ASIA: NASAL DRUG DELIVERY TECHNOLOGY MARKET SNAPSHOT
Figure 22 KEY PLAYERS ADOPTED ORGANIC AND INORGANIC GROWTH STRATEGIES BETWEEN 2014 AND 2016
Figure 23 MARKET EVOLUTION FRAMEWORK
Figure 24 BATTLE FOR MARKET SHARE: PRODUCT LAUNCHES AND APPROVALS—KEY STRATEGIES ADOPTED BY MARKET PLAYERS
Figure 25 GEOGRAPHIC REVENUE MIX OF TOP FIVE MARKET PLAYERS (2015)
Figure 26 MERCK & CO., INC.: COMPANY SNAPSHOT (2015)
Figure 27 NOVARTIS AG: COMPANY SNAPSHOT (2015)
Figure 28 GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT (2015)
Figure 29 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2015)
Figure 30 PFIZER, INC: COMPANY SNAPSHOT (2015)
Figure 31 ASTRAZENECA PLC: COMPANY SNAPSHOT (2015)
Figure 32 APTARGROUP, INC.: COMPANY SNAPSHOT (2015)
Figure 33 AEGIS THERAPEUTICS, LLC: COMPANY SNAPSHOT (2015)
Figure 34 3M: COMPANY SNAPSHOT (2015)
Figure 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2015)
Figure 36 INSIGHTS FROM INDUSTRY EXPERTS
